PCD logo

Public Health and Pharmacy: Collaborative Approaches to Improve Population Health

Public Health and Pharmacy

Public Health and Pharmacy: Collaborative Approaches to Improve Population Healthpdf icon [PDF – 832 KB]

 

 

GUEST EDITORIAL

Pharmacy Contributions to Improved Population Health: Expanding the Public Health Roundtable

Strand MA, DiPietro Mager NA, Hall L, Martin SL, Sarpong DF. Pharmacy Contributions to Improved Population Health: Expanding the Public Health Roundtable. Prev Chronic Dis 2020;17:200350.

ORIGINAL RESEARCH

PEER REVIEWED

Pharmacists in Federally Qualified Health Centers: Models of Care to Improve Chronic Disease

Rodis JL, Capesius TR, Rainey JT, Awad MH, Fox CH. Pharmacists in Federally Qualified Health Centers: Models of Care to Improve Chronic Disease. Prev Chronic Dis 2019;16:190163.

RESEARCH BRIEF

PEER REVIEWED

Continuous Stakeholder Engagement: Expanding the Role of Pharmacists in Prevention of Type 2 Diabetes Through the National Diabetes Prevention Program

Ross LW, Bana F, Blacher RJ, McDivitt J, Petty J, Beckner J, et al. Continuous Stakeholder Engagement: Expanding the Role of Pharmacists in Prevention of Type 2 Diabetes Through the National Diabetes Prevention Program. Prev Chronic Dis 2020;17:190374.

PROGRAM EVALUATION BRIEF

PEER REVIEWED

Hypertension-Focused Medication Therapy Management: A Collaborative Pilot Program Uniting Pharmacists, Public Health, and Health Insurers in Wisconsin

Thompson H, Swander L, Cohen R, Lukazewski A, Bartholow T, Pesik M, et al. Hypertension-Focused Medication Therapy Management: A Collaborative Pilot Program Uniting Pharmacists, Public Health, and Health Insurers in Wisconsin. Prev Chronic Dis 2020;17:200058.

ORIGINAL RESEARCH

PEER REVIEWED

Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department

Jakeman B, Logothetis SJ, Roberts MH, Bachyrycz A, Fortune D, Borrego ME, et al. Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department. Prev Chronic Dis 2020;17:190263.

COMMENTARY

PEER REVIEWED

Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic

Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic. Prev Chronic Dis 2020;17:200317.

RESEARCH BRIEF

PEER REVIEWED

Rx for Addiction and Medication Safety (RAMS-PEER): Evaluation of an Education and Peer Program on Opioid Misuse

Sun T, Buchanan AL, Bratberg JP, Patry E, Matson KL. Rx for Addiction and Medication Safety (RAMS-PEER): Evaluation of an Education and Peer Program on Opioid Misuse. Prev Chronic Dis 2020;17:190380.

RESEARCH BRIEF

PEER REVIEWED

Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine

Ryan G, Daly E, Askelson N, Pieper F, Seegmiller L, Allred T. Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine. Prev Chronic Dis 2020;17:190351.

ESSAY

PEER REVIEWED

The Role of the Pharmacist in Preventing Hepatitis B in the Context of the Opioid Crisis

Freeland C, Ventricelli DJ. The Role of the Pharmacist in Preventing Hepatitis B in the Context of the Opioid Crisis. Prev Chronic Dis 2020;17:200062.

ORIGINAL RESEARCH

PEER REVIEWED

Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives

Roszak SE, Ferreri SP. Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives. Prev Chronic Dis 2020;17:200050.

ORIGINAL RESEARCH

PEER REVIEWED

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

Ross LA, Bloodworth LS, Brown MA, Malinowski SS, Crane R, Sutton V, et al. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta. Prev Chronic Dis 2020;17:200063.

RESEARCH BRIEF

PEER REVIEWED

Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A1c Goal Among Patients With Type 2 Diabetes, Florida, 2017–2019

Cowart K, Updike W, Emechebe N, Zgibor J. Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A1c Goal Among Patients With Type 2 Diabetes, Florida, 2017–2019. Prev Chronic Dis 2020;17:190377.

CME ACTIVITY

PEER REVIEWED

Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019

Pathak S, Haynes M, Qato DM, Urick BY. Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019. Prev Chronic Dis 2020;17:200012.

ORIGINAL RESEARCH

PEER REVIEWED

Rural–Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017

Graves JM, Abshire DA, Undeberg M, Forman L, Amiri S. Rural–Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017. Prev Chronic Dis 2020;17:200066.

ORIGINAL RESEARCH

PEER REVIEWED

State and Regional Variation in Prescription- and Payment-Related Promoters of Adherence to Blood Pressure Medication

Yang PK, Ritchey MD, Tsipas S, Loustalot F, Wozniak GD. State and Regional Variation in Prescription- and Payment-Related Promoters of Adherence to Blood Pressure Medication. Prev Chronic Dis 2020;17:190440.

GIS SNAPSHOTS

PEER REVIEWED

Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts

Duvallet C, Hayes BD, Erickson TB, Chai PR, Matus M. Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts. Prev Chronic Dis 2020;17:200053.

ESSAY

PEER REVIEWED

Louisiana State Policies Prove Problematic for Pharmacist–Physician Collaboration

Hamilton AL, Darr M. Louisiana State Policies Prove Problematic for Pharmacist–Physician Collaboration. Prev Chronic Dis 2020;17:200051.


The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.